Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle

Molecular Therapy

Volumn 17, Issue 1, 2009, Pages 73-80

  Ohshima, Sachiko ^a,b   Shin, Jin Hong ^a,c   Yuasa, Katsutoshi ^a,d   Nishiyama, Akiyo ^a   Kira, Junichi ^b   Okada, Takashi ^a   Takeda, Shin'ichi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Pusan National University   (South Korea)

^d MUSASHINO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CD4 ANTIBODY; DYSTROPHIN; MICRODYSTROPHIN; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BREEDING LINE; CELL COUNT; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DRUG DOSAGE FORM COMPARISON; DUCHENNE MUSCULAR DYSTROPHY; EMBRYO; FEMALE; GENE EXPRESSION; GENETIC TRANSDUCTION; HINDLIMB; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INNATE IMMUNITY; MALE; MUSCLE CELL; NONHUMAN; NONVIRAL GENE THERAPY; PROTEIN EXPRESSION; SKELETAL MUSCLE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; VIRUS STRAIN; X CHROMOSOME LINKED DISORDER;

ANIMALS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; DEPENDOVIRUS; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VECTORS; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; CANIS FAMILIARIS;

EID: 58149259952     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.225     Document Type: Article

References (26)

1. Valentine, BA, Cooper, BJ, de Lahunta, A, O'Quinn, R and Blue, JT (1988). Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: Clinical studies. J Neurol Sci 88: 69-81.
2. Sharp, NJ, Kornegay, JN, Van Camp, SD, Herbstreith, MH, Secore, SL, Kettle, S et al. (1992). An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 13: 115-121.
3. J. Acta Myol 24: 145-154.
4. Nakai, H, Fuess, S, Storm, TA, Muramatsu, S, Nara, Y and Kay, MA (2005). Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice. J Virol 79: 214-224.
5. Wang, Z, Zhu, T, Qiao, C, Zhou, L, Wang, B, Zhang, J et al. (2005). Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 23: 321-328.
6. Yoshimura, M, Sakamoto, M, Ikemoto, M, Mochizuki, Y, Yuasa, K, Miyagoe-Suzuki, Y et al. (2004). AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype. Mol Ther 10: 821-828.
7. Gregorevic, P, Allen, JM, Minami, E, Blankinship, MJ, Haraguchi, M, Meuse, L et al. (2006). rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat Med 12: 787-789.
8. Yuasa, K, Yoshimura, M, Urasawa, N, Ohshima, S, Howell, JM, Nakamura, A et al. (2007). Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products. Gene Ther 14: 1249-1260.
9. Wang, Z, Kuhr, CS, Allen, JM, Blankinship, M, Gregorevic, P, Chamberlain, JS et al. (2007). Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression. Mol Ther 15: 1160-1166.
10. Li, C, Hirsch, M, Asokan, A, Zeithaml, B, Ma, H, Kafri, T et al. (2007). Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo. J Virol 81: 7540-7547.
11. Vandenberghe, LH, Wang, L, Somanathan, S, Zhi, Y, Figueredo, J, Calcedo, R et al. (2006). Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid. Nat Med 12 967-971.
12. Hagstrom, JE, Hegge, J, Zhang, G, Noble, M, Budker, V, Lewis, DL et al. (2004). A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. Mol Ther 10: 386-398.
13. Zhang, Y, Chirmule, N, Gao, G and Wilson, J (2000). CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: Role of immature dendritic cells. J Virol 74: 8003-8010.
14. Lin, SW, Hensley, SE, Tatsis, N, Lasaro, MO and Ertl, HC (2007). Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8 T cells in mice. J Clin Invest 117: 3958-3970.
15. Isotani, M, Katsuma, K, Tamura, K, Yamada, M, Yagihara, H, Azakami, D et al. (2006). Efficient generation of canine bone marrow-derived dendritic cells. J Vet Med Sci 68: 809-814.
16. Zhu, J, Huang, X and Yang, Y (2007). Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. J Virol 81: 3170-3180.
17. Zhang, Z and Wang, FS (2005). Plasmacytoid dendritic cells act as the most competent cell type in linking antiviral innate and adaptive immune responses. Cell Mol Immunol 2: 411-417.
18. Mahadevan, M, Liu, Y, You, C, Luo, R, You, H, Mehta, JL et al. (2007). Generation of robust cytotoxic T lymphocytes against prostate specific antigen by transduction of dendritic cells using protein and recombinant adeno-associated virus. Cancer Immunol Immunother 56: 1615-1624.
19. Mount, JD, Herzog, RW, Tillson, DM, Goodman, SA, Robinson, N, McCleland, ML et al. (2002). Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy. Blood 99: 2670-2676.
20. Manno, CS, Pierce, GF, Arruda, VR, Glader, B, Ragni, M, Rasko, JJ et al. (2006). Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 12: 342-347.
21. Sakamoto, M, Yuasa, K, Yoshimura, M, Yokota, T, Ikemoto, T, Suzuki, M et al. (2002). Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene. Biochem Biophys Res Commun 293: 1265-1272.
22. Okada, T, Nomoto, T, Yoshioka, T, Nonaka-Sarukawa, M, Ito, T, Ogura, T et al. (2005). Large-scale production of recombinant viruses by use of a large culture vessel with active gassing. Hum Gene Ther 16: 1212-1218.
23. Ishii, A, Hagiwara, Y, Saito, Y, Yamamoto, K, Yuasa, K, Sato, Y et al. (1999). Effective adenovirus-mediated gene expression in adult murine skeletal muscle. Muscle Nerve 22: 592-599.
24. Yuasa, K, Sakamoto, M, Miyagoe-Suzuki, Y, Tanouchi, A, Yamamoto, H, Li, J et al. (2002). Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product. Gene Ther 9: 1576-1588.
25. Araishi, K, Sasaoka, T, Imamura, M, Noguchi, S, Hama, H, Wakabayashi, E et al. (1999). Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice. Hum Mol Genet 8: 1589-1598.
26. Sandelin, A, Bailey, P, Bruce, S, Engstrom, PG, Klos, JM, Wasserman, WW et al. (2004). Arrays of ultraconserved non-coding regions span the loci of key developmental genes in vertebrate genomes. BMC Genomics 5: 99.